New federal crackdown on pill-press equipment suppliers fueling counterfeit-drug trade
S. 4446 — PRESS Act · Filed by Ashley Moody (R-FL) · 5 cosponsors · Introduced Apr 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends federal drug-trafficking law to make it illegal to manufacture or distribute pill-press machines, capsule-filling equipment, and related materials if you know or intend them to be used to make controlled substances for unlawful import into the U.S. It creates new criminal penalties (up to 8–15 years imprisonment depending on quantity) and directs the U.S. Sentencing Commission to update guidelines accordingly.
Why we flagged it
The bill's operative mechanism is a criminal prohibition on supplying equipment used to manufacture controlled substances for unlawful import. It is a law-enforcement tool targeting upstream drug-trafficking infrastructure, not a regulatory carve-out or subsidy.
What the text implies
- The 'reasonable cause to believe' standard in subsection (c)(2) is lower than 'knowledge' and may expose equipment manufacturers and chemical suppliers to criminal liability based on circumstantial evidence or industry context, potentially chilling legitimate sales of dual-use equipment.
- The bill does not define 'tableting machine' or 'encapsulating machine' with precision; legitimate pharmaceutical and supplement manufacturers may face ambiguity about whether their equipment or sales practices trigger the prohibition.
- Sentencing guidelines amendments (directed to the U.S. Sentencing Commission) are not specified in the bill itself; actual prison terms will depend on future guideline-setting, creating uncertainty about enforcement severity.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill targets drug-trafficking infrastructure (equipment suppliers) rather than users or citizens. It expands law enforcement's ability to disrupt the supply of counterfeit-drug manufacturing equipment, which reduces the flow of illicit pills (fentanyl-laced counterfeits, etc.) into communities. Citizens benefit from reduced availability of dangerous counterfeit drugs.
Named in the bill
U.S. Drug Enforcement Administration (DEA), U.S. Sentencing Commission, Controlled Substances Import and Export Act (21 U.S.C. § 952 et seq.), Title 18, United States Code (federal criminal code)
Where it stands
5 cosponsors: 5 Republicans.
- Apr 30, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Apr 30, 2026 — Referred to Senate Committee on the Judiciary · Congress.gov: “Read twice and referred to the Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,724 characters) on Nov 13, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-11-22.
“New federal crackdown on pill-press equipment suppliers fueling counterfeit-drug trade” QuorumCivic. https://share.quorumcivic.app/bill/119/s4446 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.